PRI-724
Cat. No.:YN450041
| 产品名称: | PRI-724 |
| CAS No.: | 1422253-38-0 |
| Chemical Name: | (6S,9S,9aS)-Hexahydro-2,9-dimethyl-4,7-dioxo-N-(phenylmethyl)-6-[[4-(phosphonooxy)phenyl]methyl]-8-(8-quinolinylmethyl)-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide |
| Synonyms: | Foscenvivint,C-82 prodrug,ICG-001 analog |
| 分子量: | 658.64 |
| 分子式: | C₃₃H₃₅N₆O₇P |
| SMILES: | O=C(N([C@]([C@H](C)N1CC2=C3N=CC=CC3=CC=C2)([H])N4[C@@H](CC5=CC=C(OP(O)(O)=O)C=C5)C1=O)N(C)CC4=O)NCC6=CC=CC=C6 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | PRI-724 选择性抑制CBP/β-catenin相互作用。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Lenz, H. et al.: Cancer Science (2014), 105(9), 1087-1092